In view of the ethical and moral objections concerning the application for therapeutic purposes embryonic stem cells (EC) - in many laboratories began work to genome reprogramming differentiated somatic cells such as skin fibroblasts. The aim is to obtain in this way the properties of cells bypassing the EC cell of any claims of a non medical device. Description of the tests are successfully nieuwieńczonych is contained in the following text.